Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1321756
Disease: Achalasia
Achalasia
0.040 Biomarker disease BEFREE Increased lower esophageal sphincter integrated relaxation pressure (LES-IRP) is a cardinal feature of achalasia. 30153516 2019
CUI: C0014848
Disease: Esophageal Achalasia
Esophageal Achalasia
0.040 Biomarker disease BEFREE Gastro-esophageal reflux disease (GERD) may occur post-achalasia intervention due to disruption of the LES and therefore requires diligent follow-up, especially in children treated with POEM. 29439587 2018
CUI: C0014848
Disease: Esophageal Achalasia
Esophageal Achalasia
0.040 Biomarker disease BEFREE The resting LES pressure was 8.9±5.94 mmHg with GER symptoms, 16.4±12.79 mmHg without GER symptoms, and 26.8±14.03 mmHg with achalasia. 29915812 2018
CUI: C1321756
Disease: Achalasia
Achalasia
0.040 Biomarker disease BEFREE The resting LES pressure was 8.9±5.94 mmHg with GER symptoms, 16.4±12.79 mmHg without GER symptoms, and 26.8±14.03 mmHg with achalasia. 29915812 2018
CUI: C1321756
Disease: Achalasia
Achalasia
0.040 Biomarker disease BEFREE Gastro-esophageal reflux disease (GERD) may occur post-achalasia intervention due to disruption of the LES and therefore requires diligent follow-up, especially in children treated with POEM. 29439587 2018
CUI: C0014868
Disease: Esophagitis
Esophagitis
0.020 GeneticVariation disease BEFREE HR-Manometry showed a similar reduction in the LES pressure and 4sIRP; 24-h pH-monitoring showed however an abnormal exposure to acid in 38.4% of POEM patients, as compared to 17.1% of LHD patients (p < 0.01) and esophagitis was found in 37.4% of the POEM and 15.2% of LHD patients (p < 0.05). 31848870 2020
CUI: C0014868
Disease: Esophagitis
Esophagitis
0.020 Biomarker disease BEFREE The A factor (the degree of hiatal hernia), P factor (the degree of esophagitis), and pH < 4 holding time significantly improved after surgery compared with prior to surgery (p < 0.001 for all), while the LES lengths and abdominal LES lengths were extended (p < 0.001 for each). 30225741 2018
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.020 Biomarker disease BEFREE Nevertheless, highest resistance was documented for the nonmutator CF epidemic strain LES-1 (ST-146) detected for the first time in Spain. 23951065 2013
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.020 GeneticVariation disease BEFREE Polymorphisms in the genes encoding ABO blood type, secretor or Lewis genotypes were not shown to associate with severity of CF lung disease, or age of onset of P. aeruginosa infection, nor was there any association with other clinical phenotypes in a group of 808 patients homozygous for the DeltaF508 mutation. 19169360 2009
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.020 Biomarker disease BEFREE The strong correlation between the promoter activity of the FUT III gene and the high expression of sialyl Le(a) observed in different colon carcinoma cell lines seem to confirm the important regulatory role of FUT3 in the synthesis of sialyl Le(a). 16199102 2005
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.020 AlteredExpression disease BEFREE Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. 8909999 1996
CUI: C0002871
Disease: Anemia
Anemia
0.010 Biomarker disease BEFREE Moreover, LES-LAPG may be advantageous for anemia prevention and nutritional status improvement compared to LAPG-DTA. 30591490 2019
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE These results indicate that serum OPN levels were strongly associated with subclinical atherosclerosis in patients with LES and it might be a useful CV biomarker that requires additional validation in larger trials. 30767212 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE These results indicate that serum OPN levels were strongly associated with subclinical atherosclerosis in patients with LES and it might be a useful CV biomarker that requires additional validation in larger trials. 30767212 2019
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.010 Biomarker disease BEFREE However, after controlling for depression severity, significant differences between Q-LES-Q and Zung-SAS scores disappeared in MDD and BP. 30292023 2019
CUI: C0011168
Disease: Deglutition Disorders
Deglutition Disorders
0.010 Biomarker group BEFREE Longer myotomy on the gastric side (>2.5 cm) ensures complete division of the LES with better outcomes in term of resolution of dysphagia but may be associated with higher postoperative GERD. 31012870 2019
CUI: C0040558
Disease: Toxoplasmosis
Toxoplasmosis
0.010 Biomarker disease BEFREE FUT3 and FUT2 genotyping and glycoconjugate profile Lewis<sup>b</sup> as a protective factor to Toxoplasma gondii infection. 30831115 2019
Secondary malignant neoplasm of bone
0.010 Biomarker disease BEFREE E-selectin binding activity mediated by the α1-3 fucosyltransferases Fut3/Fut6 and Glg1 are instrumental to the formation of bone metastasis. 30988423 2019
CUI: C0338106
Disease: Adenocarcinoma of colon
Adenocarcinoma of colon
0.010 AlteredExpression disease BEFREE Additionally, mRNA levels of fucosyltransferase 3 (FUT3) and 6 (FUT6) were found to be high in the TRAIL-sensitive colon adenocarcinoma cell line COLO 205. 30589515 2019
Secondary malignant neoplasm of pancreas
0.010 Biomarker disease BEFREE Overexpressed N-fucosylation on the cell surface driven by FUT3, 5, and 6 promotes cell motilities in metastatic pancreatic cancer cell lines. 30808544 2019
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.010 Biomarker disease BEFREE However, after controlling for depression severity, significant differences between Q-LES-Q and Zung-SAS scores disappeared in MDD and BP. 30292023 2019
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.010 GeneticVariation group BEFREE A luciferase reporter assay was performed using two breast tumor cell lines to evaluate respectively the impact of FUT3 rs2306969 (-6951 CC) and (-6951 TT) on protein expression. 30929162 2019
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.010 GeneticVariation disease BEFREE Among patients with FUT3 alleles that encode a functional protein, levels of CA19-9 above the SNP-determined cutoff values identified 66.4% of patients with PDAC, with 99.3% specificity. 31676359 2019
CUI: C3150911
Disease: GASTRIC CANCER, INTESTINAL
GASTRIC CANCER, INTESTINAL
0.010 GeneticVariation disease BEFREE Tumor-associated FUT3 promoter polymorphism rs2306969 (-6951 C> T, position related to the gene's translation start site) has been linked to breast, ovarian and intestinal gastric cancer. 30929162 2019
CUI: C0018834
Disease: Heartburn
Heartburn
0.010 GeneticVariation phenotype BEFREE There was a prevalence of acid reflux at both sphincters (p<0.0001); liquid reflux was prevalent at the LES (p=0.003) and mixed reflux at the UES (p=0.0001). 29307652 2018